Healthcare -
Biotechnology - NASDAQ - US
$ 39.3
1.58 %
$ 11 B
Market Cap
22.33
P/E
EXEL - OTHER CURRENT ASSETS
Other Current Assets EXEL - Exelixis, Inc.
68.5 M
LAST VALUE
4.92%
2 YEAR CAGR
20.47%
5 YEAR CAGR
15.87%
10 YEAR CAGR